BRPI0407548A - composições compreendendo um componente polissacarìdeo e uma ou mais camadas de revestimento - Google Patents

composições compreendendo um componente polissacarìdeo e uma ou mais camadas de revestimento

Info

Publication number
BRPI0407548A
BRPI0407548A BRPI0407548-0A BRPI0407548A BRPI0407548A BR PI0407548 A BRPI0407548 A BR PI0407548A BR PI0407548 A BRPI0407548 A BR PI0407548A BR PI0407548 A BRPI0407548 A BR PI0407548A
Authority
BR
Brazil
Prior art keywords
layer
surrounding
surrounding layer
compositions
arabinose
Prior art date
Application number
BRPI0407548-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Graham John Myatt
Paul Alfred Cimiluca
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/369,039 external-priority patent/US20040161471A1/en
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BRPI0407548A publication Critical patent/BRPI0407548A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0407548-0A 2003-02-18 2004-02-18 composições compreendendo um componente polissacarìdeo e uma ou mais camadas de revestimento BRPI0407548A (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US36851403A 2003-02-18 2003-02-18
US36851003A 2003-02-18 2003-02-18
US10/369,039 US20040161471A1 (en) 2003-02-18 2003-02-18 Compositions comprising a plurality of particles or agglomerates having a defined particle size
US10/633,965 US7026303B2 (en) 2003-02-18 2003-08-04 Compositions comprising a polysaccharide component and one or more coating layers
PCT/US2004/004653 WO2004073636A2 (en) 2003-02-18 2004-02-18 Compositions comprising a polysaccharide component and one or more coating layers

Publications (1)

Publication Number Publication Date
BRPI0407548A true BRPI0407548A (pt) 2006-02-14

Family

ID=32913221

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0407548-0A BRPI0407548A (pt) 2003-02-18 2004-02-18 composições compreendendo um componente polissacarìdeo e uma ou mais camadas de revestimento

Country Status (9)

Country Link
US (1) US7026303B2 (pl)
EP (1) EP1594463A2 (pl)
JP (1) JP2006515009A (pl)
AR (1) AR043223A1 (pl)
BR (1) BRPI0407548A (pl)
CA (1) CA2514889A1 (pl)
MX (1) MXPA05008790A (pl)
PL (1) PL379029A1 (pl)
WO (1) WO2004073636A2 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8732086B2 (en) 2003-01-02 2014-05-20 Catch Media, Inc. Method and system for managing rights for digital music
CN1886427B (zh) 2003-11-28 2012-05-23 伊士曼化工公司 纤维素共聚体和氧化方法
WO2009036294A1 (en) * 2007-09-14 2009-03-19 Tic Gums, Inc. Super dispersible gums and powders and process for making the same
KR101766619B1 (ko) 2008-12-31 2017-08-08 알데릭스, 인코포레이티드 체액 저류 또는 염 과부하와 연관된 장애 및 위장관 장애의 치료 시에 ｎｈｅ-매개된 역수송을 억제하는 화합물 및 방법
WO2018129556A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US20110217426A1 (en) * 2010-03-04 2011-09-08 Perry Stephen C Enteric coating composition
EP2568828B1 (en) 2010-05-08 2016-09-21 Biofiber-Damino A/S Agglomerated oil impregnated psyllium husk
US10376481B2 (en) 2012-08-21 2019-08-13 Ardelyx, Inc. Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
HK1211469A1 (en) 2012-08-21 2016-05-27 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
AU2014250956B2 (en) 2013-04-12 2019-04-04 Ardelyx, Inc. NHE3-binding compounds and methods for inhibiting phosphate transport
BR112019013963A2 (pt) 2017-01-09 2020-04-28 Ardelyx Inc inibidores de antiporte mediado por nhe
KR102669987B1 (ko) 2017-01-09 2024-05-31 알데릭스, 인코포레이티드 위장관 장애를 치료하는 데 유용한 화합물
DE102017108054A1 (de) * 2017-04-13 2018-10-18 Natura Werk Gebr. Hiller GmbH & Co. KG Essbare Zusammensetzung zur Verdauungsförderung

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321263A (en) * 1980-09-30 1982-03-23 Rowell Laboratories, Inc. Psyllium compositions
US4548806A (en) * 1982-07-23 1985-10-22 G. D. Searle & Co. Psyllium hydrophilic mucilloid composition
US5009916A (en) * 1983-12-12 1991-04-23 The Procter & Gamble Company Psyllium mucilloid fiber food products
US4999200A (en) * 1987-12-09 1991-03-12 Marion Laboratories Psyllium tablet composition, method of manufacture and method of use
US5219570A (en) * 1989-08-10 1993-06-15 The Procter & Gamble Company Agglomerated psyllium husk containing edible acid
US5320847A (en) * 1993-05-13 1994-06-14 Valentine Enterprises, Inc. Agglomerated psyllium hydrophilic mucilloid combinates
US5356618A (en) * 1993-05-14 1994-10-18 The Procter & Gamble Company Psyllium drink mix compositions
US5424945A (en) * 1993-08-31 1995-06-13 Xerox Corporation System for evaluating a psychological effect of a document
US5651988A (en) 1995-08-18 1997-07-29 Xyrofin Oy Combination osmotic and bulk forming laxatives
US6045847A (en) * 1997-11-13 2000-04-04 Fuji Oil Co., Ltd. Rice cooking method
US6287609B1 (en) * 1999-06-09 2001-09-11 Wisconsin Alumni Research Foundation Unfermented gel fraction from psyllium seed husks
US7014862B2 (en) 2002-05-20 2006-03-21 The Procter & Gamble Company Chewable compositions containing a gel-forming extract of psyllium

Also Published As

Publication number Publication date
EP1594463A2 (en) 2005-11-16
PL379029A1 (pl) 2006-06-26
US20040162267A1 (en) 2004-08-19
JP2006515009A (ja) 2006-05-18
AR043223A1 (es) 2005-07-20
WO2004073636A3 (en) 2005-04-14
US7026303B2 (en) 2006-04-11
MXPA05008790A (es) 2005-10-18
WO2004073636A2 (en) 2004-09-02
CA2514889A1 (en) 2004-09-02

Similar Documents

Publication Publication Date Title
BRPI0407548A (pt) composições compreendendo um componente polissacarìdeo e uma ou mais camadas de revestimento
BRPI0519088A2 (pt) formulaÇÕes de tacrolimo nanoparticuladas
BRPI0309142C1 (pt) suspensão de microcápsulas em uma fase líquida aquosa, que permite a liberação modificada de pelo menos um princípio ativo com exclusão da amoxicilina e que é destinada a ser administrada por via oral
DE60325718D1 (de) Nystatin-nanopartikelzusammensetzungen
ATE531368T1 (de) Tacrolimus enthaltende zusammensetzungen mit modifizierter freisetzung
RU2009109353A (ru) Композиции на основе наночастиц
EA200702444A1 (ru) Композиции с наночастицами клопидогреля
BRPI0705488A (pt) composição nanoparticulada estável, métodos de preparar a mesma e de prevenir e/ou tratar uma infecção bacteriana, composição farmacêutica, e, forma de dosagem
DE60217367D1 (de) Nanopartikelzusammensetzungen enthaltend insulin
BRPI0407375A (pt) Métodos para tratar dor por meio da administração de um antagonista do fator de crescimento neural e u nsaid e composições contendo os mesmos
CN102665655A (zh) W/o型乳化化妆品
EP2481402A3 (en) Nanoparticle comprising rapamycin and albumin as anticancer agent
EA200701442A1 (ru) Композиции наночастиц кандесартана
EA200702638A1 (ru) Стабильная композиция (рецептура) с наночастицами ацетаминофена
BRPI0416239A (pt) método para preparar partìculas de submìcron de paclitaxel
JP2009538269A5 (pl)
ATE418555T1 (de) A2a-adenosinrezeptorantagonisten
BR0313220A (pt) Pelìcula de revestimento para comprimidos e cápsulas
BRPI0512644A (pt) composições de branqueamento fluorescente encapsulado para melhorar o aspecto superficial
WO2008008879A3 (en) Nanoparticulate formulations of modafinil
BRPI0510408A (pt) composições autovaporizantes, artigos compreendendo essas composições e métodos para preparo das mesmas
BR0207065A (pt) Pelìculas biaxialmente orientadas de baixo brilho compreendendo polìmeros aromáticos de vinila e partìculas de borracha substancialmente não esféricas
BRPI0513845A (pt) aglomeração de partìculas de esterol tendo um tamanho particular
BR0314117A (pt) Uso tópico de alumina calcinada microfina
BRPI0614080A2 (pt) Composição e método para a preparação de uma cefalosporina nanoparticulada, para o tratamento de doença bacteriana e para a prevenção e/ou tratamento de osteoporose

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A , 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011.